Clemensson L: Difference between revisions
From Bioblast
Beno Marija (talk | contribs) No edit summary |
Beno Marija (talk | contribs) No edit summary |
||
| Line 14: | Line 14: | ||
== Participated at == | == Participated at == | ||
::::* [[FAT4BRAIN Midterm Review meeting Virtual]] | |||
::::* [[FAT4BRAIN Kick-off meeting Riga LV]] | ::::* [[FAT4BRAIN Kick-off meeting Riga LV]] | ||
::::*[[MiP2018/MitoEAGLE Jurmala LV|MitoEAGLE 2018 Jurmala LV]] | ::::*[[MiP2018/MitoEAGLE Jurmala LV|MitoEAGLE 2018 Jurmala LV]] | ||
Revision as of 14:43, 27 April 2021
| Name | Clemensson Laura, |
|---|---|
| Institution | University of Uppsala, Department of Neuroscience  Functional Pharmacology |
| Address | BMC, Box 593,, 751 24 |
| City | Uppsala |
| State/Province | |
| Country | Sweden |
| [email protected] | |
| Weblink | |
| O2k-Network Lab |
Labels:
Publications
| Published | Reference | |
|---|---|---|
| Liepinsh 2024 Br J Pharmacol | 2024 | Liepinsh E, Zvejniece L, Clemensson L, Ozola M, Vavers E, Cirule H, Korzh S, Skuja S, Groma V, Briviba M, Grinberga S, Liu W, Olszewski P, Gentreau M, Fredriksson R, Dambrova M, SchiΓΆth HB (2024) Hydroxymethylglutaryl-CoA reductase activity is essential for mitochondrial Ξ²-oxidation of fatty acids to prevent lethal accumulation of long-chain acylcarnitines in the mouse liver. Br J Pharmacol [Epub ahead of print]. https://doi.org/10.1111/bph.16363 |
Abstracts
| Published | Reference | |
|---|---|---|
| Clemensson 2018 MiP2018 | 2018 | |
